Streetbeat News

Equity Actions

SILO

Silo Pharma, Inc. (NASDAQ:SILO) announced a $2.1M registered direct offering of 763,638 shares of common stock at $2.75 per share, priced at-the-market under Nasdaq rules. The company will also issue unregistered warrants for the same number of shares at the same price in a concurrent private placement. The offering is expected to close around July 22, 2024, with H.C. Wainwright & Co. acting as the exclusive placement agent.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 12:02 pm

KITT

Nauticus Robotics shares are trading lower after the company announced a 1-for-36 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 11:44 am

NVDA

SERV

Serve Robotics shares are trading higher after Nvidia disclosed a stake in the company through a Form4 filing.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 11:43 am

BHC

Bausch Health Companies announced that Jean-Jacques Charhon will join as CFO on August 19, 2024, and Aimee Lenar joined as Executive Vice President, US Pharma on July 15, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 11:17 am

PLUG

Plug Power has announced the pricing of its public offering of 78.74 million shares at $2.54 per share, expected to close around July 22, 2024. The gross proceeds are anticipated to be approximately $200 million, which will be used for general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 11:14 am

PLUG

Plug Power shares are trading lower following the announcement of a $200 million public offering of its common stock.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 10:54 am

LODE

Comstock has retired its existing equity purchase agreement and entered into a new securities purchase agreement with an investor for an 8.0% convertible promissory note due October 31, 2025. The note has a principal amount of $2.717 million, purchased for $2.50 million, with an 8% original issue discount. Part of the proceeds will be used to redeem $500,000 of existing convertible debt, reducing the company's outstanding obligations.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 10:03 am

VSAC

VSAC has successfully applied to migrate to the Nasdaq Capital Market, which could enhance its visibility and liquidity.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 6:47 am

SMLP

Summit Midstream Partners (SMLP) announced unitholders' approval for its conversion to a C-corporation and the expansion of its credit facility to $500 million. This move aims to reduce tax burdens, simplify equity ownership, enhance trading liquidity, and provide greater transparency for investors.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 6:41 am

ARTV

Artiva Biotherapeutics has priced its upsized $167 million initial public offering (IPO) of 13.92 million common shares at $12 per share. The shares will begin trading on the Nasdaq Global Market under the symbol 'ARTV' on July 19, 2024, with the offering expected to close on July 22, 2024, pending customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 6:27 am